SCHEMBL6026586

SCHEMBL6026586

O=C(NCc1ccccc1)C1(Nc2ccc(F)cc2)CCNCC1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.51
POLB P06746 2/20 0.51
NPC1 O15118 1/20 0.51
MAOB P27338 1/20 0.51
ALDH1A1 P00352 6/20 0.49
PLA2G1B P04054 1/20 0.46
ATG4B Q9Y4P1 1/20 0.46
LMNA P02545 3/20 0.45
TACR1 P25103 1/20 0.45
KMT2A Q03164 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
ATM Q13315 1/20 0.43
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43
MEN1 O00255 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
OPRL1 P41146 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4781784 0.91 ATM (0.47) RAB9APOLBNPC1MAOBTACR1
SCHEMBL6859676 0.88 MEN1 (0.47) RAB9APOLBNPC1ALDH1A1LMNA
SCHEMBL16876727 0.88 L3MBTL1 (0.49) ALDH1A1TACR1KMT2AATMHPGD
SCHEMBL6017363 0.88 SMN1; SMN2 (0.56) RAB9ANPC1ALDH1A1TACR1KMT2A
SCHEMBL16876692 0.87 TACR1 (0.45) RAB9APOLBNPC1MAOBALDH1A1
SCHEMBL16876706 0.86 TACR1 (0.46) RAB9APOLBNPC1MAOBALDH1A1
SCHEMBL16876714 0.84 GAA (0.51) RAB9ANPC1ALDH1A1LMNATACR1
SCHEMBL16876745 0.84 TP53 (0.45) RAB9ANPC1LMNATACR1KMT2A
SCHEMBL16876689 0.84 TACR1 (0.43) RAB9APOLBNPC1ALDH1A1TACR1
SCHEMBL16876742 0.84 TACR1 (0.44) RAB9APOLBNPC1MAOBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3092228-A1 TRPA1 MODULATORS Algomedix, Inc. (US) 2016-11-16 EP disclosed
WO-2015103060-A1 TRPA1 MODULATORS ALGOMEDIX, INC. (US) 2015-07-09 WO disclosed
EP-1678177-A1 TRIAZA-SPIROPIPERIDINE DERIVATIVES FOR USE AS GLYT-1 INHIBITORS IN THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS F.HOFFMANN-LA ROCHE AG (CH) 2006-07-12 EP disclosed
WO-2005040166-A1 TRIAZA-SPIROPIPERIDINE DERIVATIVES FOR USE AS GLYT-1 INHIBITORS IN THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS F.HOFFMANN-LA ROCHE AG (CH) 2005-05-06 WO disclosed
EP-0696280-A1 SUBSTITUTED PYRROLIDIN-3-YL-ALKYL-PIPERIDINES USEFUL AS TACHYKININ ANTAGONISTS MERRELL DOW PHARMA (US) 1996-02-14 EP disclosed
WO-1994026735-A1 SUBSTITUTED PYRROLIDIN-3-YL-ALKYL-PIPERIDINES USEFUL AS TACHYKININ ANTAGONISTS MERRELL DOW PHARMACEUTICALS INC. (US) 1994-11-24 WO disclosed